EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Microbiome unlocks cancer immunotherapeutic potential: State of the art and future

Han-Yue Luo, Lei-Ming Cao, Kan Zhou, Yao Xiao, Zi-Zhan Li, Bing Liu, Lin-Lin Bu

Seminars in Cancer Biology · 2025-11 · 116 · 1-21

DOI: 10.1016/j.semcancer.2025.08.001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2025-11. Verfasst von Han-Yue Luo und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Lab…. Hauptthemen laut MEDLINE: Neoplasms, Immunotherapy, Microbiota. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 252 Literaturangaben. Gefördert von: Wuhan University, Fundamental Research Funds for the Central Universities, Hubei Province Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy has overturned the traditional perception of cancer treatment and brought new vitality to the field of oncology, but it still has unresolved problems such as a low response rate and severe side effects. The microbiome has been found to be involved in tumorigenesis, progression, metastasis and immunity modulation. Especially in immunity, the microbiome plays a key role through delicate mechanisms that regulate the immune response not only from the whole body to the local tumor microenvironment but also from innate to adaptive immunity. We summarize the specific relationship between tumor-associated microbiomes at different sites (gut, oral, intratumoral) and cancer immunity, especially pay attention to the microbiome besides the gut. The microbiome-based immunotherapy has been innovatively categorized as follows. ⅰ) Bacteria-based immunotherapy and engineered bacteria as a new strategy to be used in immunotherapy. ⅱ) Microbiome combined with immunotherapy to improve efficacy and mitigate side effects. Finally, we conclude with insights into the shortcomings and future directions of microbiome in immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsImmunotherapyMicrobiotaHumansTumor MicroenvironmentAnimalsGastrointestinal Microbiome

Stichwörter der Autor:innen

cancerdrug delivery systemimmunityimmunotherapymicrobiome

Autor:innen und Institutionen

  • State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan Univer…

Förderung

  • Wuhan University
  • Fundamental Research Funds for the Central Universities
  • Hubei Province Natural Science Foundation

Zitieren

APA

Luo, H. Y., Cao, L. M., Zhou, K., Xiao, Y., Li, Z. Z., Liu, B., & Bu, L. L. (2025). Microbiome unlocks cancer immunotherapeutic potential: State of the art and future. Seminars in Cancer Biology, 116, 1-21. https://doi.org/10.1016/j.semcancer.2025.08.001

Vancouver

Luo HY, Cao LM, Zhou K, Xiao Y, Li ZZ, Liu B, et al. Microbiome unlocks cancer immunotherapeutic potential: State of the art and future. Seminars in Cancer Biology. 2025;116:1-21. doi:10.1016/j.semcancer.2025.08.001

BibTeX
@article{Luo2025,
  author = {Luo, Han-Yue and Cao, Lei-Ming and Zhou, Kan and Xiao, Yao and Li, Zi-Zhan and Liu, Bing and Bu, Lin-Lin},
  title = {Microbiome unlocks cancer immunotherapeutic potential: State of the art and future},
  journal = {Seminars in Cancer Biology},
  year = {2025},
  volume = {116},
  pages = {1--21},
  doi = {10.1016/j.semcancer.2025.08.001}
}
Kostenlos starten →